Humira facing building pressure in EU as Samsung, Biogen get nod for biosimilar

23rd June 2017 Uncategorised 0

A new flank is opening up in the assault on Humira, the world’s best-selling drug, as the European Medicines Agency today recommended approval of Imraldi, a Humira biosimilar from Samsung and Biogen.

More: Humira facing building pressure in EU as Samsung, Biogen get nod for biosimilar
Source: fierce